https://biotechmorning.com/news/repligen-biolife-solutions-acquisition-bioprocessing Biotech Morning en 2026-08-23T14:17:58.556Z Repligen Just Bought Its Way Into Cell Therapy's Plumbing https://biotechmorning.com/news/fda-commissioner-kalvista-rare-disease-drug-rejection Biotech Morning en 2026-08-23T14:17:11.441Z The FDA Commissioner Tried to Kill a Rare Disease Drug. It Didn't Work. https://biotechmorning.com/news/lilly-ataibeckley-psychedelic-acquisition Biotech Morning en 2026-08-23T14:16:29.142Z Lilly Just Dropped $3.8 Billion on a Psychedelic Trip https://biotechmorning.com/news/moderna-merck-mrna-cancer-vaccine-melanoma-phase-3 Biotech Morning en 2026-08-23T14:15:42.324Z The Vaccine That Isn't for a Virus https://biotechmorning.com/news/australia-first-h5n1-mammal-seal Biotech Morning en 2026-08-23T14:14:55.330Z A Seal in South Australia Just Became a Pandemic Warning Sign https://biotechmorning.com/news/taiho-cullinan-lung-cancer-challenge-jj Biotech Morning en 2026-08-23T14:14:12.909Z J&J Built a Lung Cancer Empire. Two Underdogs Just Crashed the Gates. https://biotechmorning.com/news/ptc-therapeutics-fabry-disease-gene-therapy-bankruptcy Biotech Morning en 2026-08-23T14:13:27.563Z PTC Therapeutics Just Bought a Gene Therapy Out of Bankruptcy Court https://biotechmorning.com/news/eli-lilly-750m-resilience-kwikpen-manufacturing Biotech Morning en 2026-08-23T14:12:42.464Z Eli Lilly Just Dropped $750M on a Factory. The Reason? A Pen. https://biotechmorning.com/news/kennedy-hhs-vaccine-policy-document-details Biotech Morning en 2026-08-22T14:18:26.359Z Inside Kennedy's Vaccine Playbook: What a Leaked HHS Document Tells Us https://biotechmorning.com/news/polish-company-matched-ozempic-novo-nordisk Biotech Morning en 2026-08-22T14:17:43.868Z A Polish Company Just Matched Ozempic. Novo Nordisk Should Be Nervous. https://biotechmorning.com/news/capricor-duchenne-fda-rejection-activist-investor Biotech Morning en 2026-08-22T14:17:02.271Z Capricor's Duchenne Drug Just Hit a Wall. Then the Activist Investors Showed Up. https://biotechmorning.com/news/supernus-indivior-cns-merger-2 Biotech Morning en 2026-08-22T14:16:08.960Z Two Mid-Cap Pharma Companies Just Bet They're Better Together https://biotechmorning.com/news/sarepta-elevidys-black-box-warning-job-cuts Biotech Morning en 2026-08-22T14:15:24.796Z Sarepta's $900M Drug Just Got the FDA's Scariest Label https://biotechmorning.com/news/sentynl-mereo-475m-rare-lung-disease-deal Biotech Morning en 2026-08-22T14:14:37.008Z The $475M Bet on a Lung Disease Most Doctors Miss https://biotechmorning.com/news/werewolf-therapeutics-ambros-reverse-merger-painkiller Biotech Morning en 2026-08-22T14:13:48.599Z A Werewolf Just Became a Painkiller Company https://biotechmorning.com/news/sandoz-henlius-322-million-biosimilar-deal Biotech Morning en 2026-08-22T14:13:00.699Z Sandoz Just Went Shopping in Shanghai for $322 Million https://biotechmorning.com/news/4-1bb-first-drug-filing-leads-biolabs Biotech Morning en 2026-08-22T14:12:17.970Z The Target Big Pharma Couldn't Crack Just Got Its First Drug Filing https://biotechmorning.com/news/resilience-cdmo-bankruptcy-six-sites-closing Biotech Morning en 2026-08-22T14:11:28.453Z The $2 Billion Biotech Factory That's Shutting Half Its Lights Off